newsfilter
← Latest News
GlobeNewswire·

NANOBIOTIX Statement Regarding Recent Media Speculation

PARIS and CAMBRIDGE, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients